Trials / Unknown
UnknownNCT05049395
HFNO Reducing the Incidence of Hypoxia for Hysteroscopy Sedated With Propofol
HFNO Reducing the Incidence of Hypoxia During the Procedure of Hysteroscopy Sedated With Propofol，a Randomized, Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 960 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
To determine whether high-flow nasal cannula oxygen can reduce the incidence of hypoxia during the procedure of sedated hysteroscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | High Flow Nasal Cannula oxygen (HFNO) | The AIRVO2 is set at 30L/min, FiO2 100%, and 37℃ before anesthesia induction，and then 60L/min until the end of the procedure of sedated hysteroscopy. |
| DEVICE | Regular oxygen | The patients are administered oxygen of 3L-6L/min until the end of the hysteroscopy operation. |
Timeline
- Start date
- 2021-09-30
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2021-09-20
- Last updated
- 2021-10-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05049395. Inclusion in this directory is not an endorsement.